z-logo
open-access-imgOpen Access
Cytotoxic Synergism between a Proprietary Commiphora mukul Gum Extract GU-MCT810, 2-deoxy-D-glucose, and Metformin in Human Alveolar Rhabdomyosarcoma and Hepatoma Cell Lines In vitro
Author(s) -
Cheppail Ramachandran,
KarlWerner Quirin,
Steven J. Melnick
Publication year - 2021
Publication title -
journal of complementary and alternative medical research
Language(s) - English
Resource type - Journals
ISSN - 2456-6276
DOI - 10.9734/jocamr/2021/v16i430307
Subject(s) - metformin , cytotoxic t cell , alveolar rhabdomyosarcoma , in vitro , rhabdomyosarcoma , cell culture , pharmacology , chemistry , cytotoxicity , medicine , biology , endocrinology , sarcoma , diabetes mellitus , biochemistry , pathology , genetics
In this investigation we have analyzed the synergism for the cytotoxic effect of a proprietary guggul gum extract (GU), 2-deoxy-D-glucose (2-DG) and metformin (Met) in SJRH30 human alveolar rhabdomyosarcoma and HepG2 hepatoma cell lines in vitro. 2-DG and Met as single agents have weak cytotoxic effects in both cell lines. However, the combination of GU+2-DG, GU+Met and 2-DG+Met showed synergism for cytotoxic effect by CompuSyn analysis. Therefore, GU can be included in the combination of drugs involving 2-DG and Met to have synergistic effect. GU also showed a dose-dependent increase in cellular glucose uptake in HepG2 cells like the antidiabetic drug 2,4-thiozolidine dione (TZ). The demonstration of synergism of anticancer effects between GU, metformin and 2-DG, suggest that their mechanisms are in general complementary, though further studies are required to delineate the mechanism of GU, 2-DG and metformin combinations.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom